Key result
Each kilogram increase in handgrip strength is linked to ~4% lower mortality in MI survivors.
Why the study?
Does higher handgrip strength correlate with reduced all-cause and cardiovascular mortality in myocardial infarction survivors?
Cohort (n=376)
Yes
Does higher handgrip strength correlate with reduced all-cause and cardiovascular mortality in myocardial infarction survivors?
Effect estimate: HR 0.96 (95% CI 0.95-0.98)
p-value: p=< .001
Higher handgrip strength is independently associated with lower all-cause and cardiovascular mortality in MI survivors, highlighting its prognostic value.
May support HGS for post-MI risk stratification; leaves open whether strength interventions improve survival.
Handgrip strength (HGS) predicts adverse health outcomes, yet its association with mortality in myocardial infarction (MI) survivors remains incompletely characterized. This study examines correlations between HGS and cardiovascular/all-cause mortality in MI survivors. This cohort study used data from National Health and Nutrition Examination Survey. Multivariable-adjusted Cox proportional hazards models quantified associations of HGS (continuous and categorical) with mortality. Stratified and interaction analyses elucidated these relationships. Among 376 MI survivors (231 men and 145 women), each kilogram increase in HGS correlated with reduced all-cause mortality (hazard ratio [HR] 0.96, 95% confidence interval [CI] 0.95-0.98; P < .001) and cardiovascular mortality (HR 0.95, 95% CI 0.93-0.97; P < .001). Nondiabetic individuals in the highest HGS tertile demonstrated lower all-cause mortality (HR 0.10, 95% CI 0.04-0.24) and cardiovascular mortality (HR 0.02, 95% CI 0.00-0.16) versus the lowest tertile. Diabetic participants in the highest tertile exhibited reduced all-cause (HR 0.28, 95% CI 0.11-0.74; P = .011) and cardiovascular mortality (HR 0.16, 95% CI 0.04-0.69; P = .014). In this US national cohort of MI survivors, higher HGS was independently associated with lower all-cause and cardiovascular mortality, though the association was attenuated in individuals with diabetes. These findings highlight the prognostic value of muscular strength and underscore the need for trials to test whether strength-enhancing interventions, particularly in high-risk groups, can improve survival.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2026) conducted a cohort in Myocardial infarction survivors (n=376). Handgrip strength was evaluated on All-cause mortality (HR 0.96, 95% CI 0.95-0.98, p=< .001). Each kilogram increase in handgrip strength among myocardial infarction survivors was associated with reduced all-cause mortality (HR 0.96; 95% CI 0.95-0.98; P<0.001) and cardiovascular mortality.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: